申请人:Saito Tetsuji
公开号:US20100137318A1
公开(公告)日:2010-06-03
A compound of a formula (I):
wherein R
1
represents a C3-10 branched alkyl group which may be substituted; R
2
represents a hydrogen atom or a C1-4 alkyl group which may be substituted; R
3
represents a C1-4 alkyl group which may be substituted or a halogen atom; R
4
represents a C1-4 alkyl group which may be substituted; and ring 1 represents a cyclic group which has planarity and may have a substituent group, a salt thereof, an N-oxide thereof or a solvate thereof, or a prodrug thereof, is useful as a medicinal component having CRF antagonistic activity for the prevention and/or treatment of a neuropsychiatric disease, a peripheral organ disease and the like.
化合物的化学式(I):其中R1代表一个C3-10支链烷基,可以被取代; R2代表氢原子或C1-4烷基,可以被取代; R3代表C1-4烷基,可以被取代或卤素原子; R4代表C1-4烷基,可以被取代; 环1表示具有平面性且可能具有取代基团的环状基团,其盐,其N-氧化物或其溶剂化物,或其前药,可用作具有CRF拮抗活性的药物成分,用于预防和/或治疗神经精神疾病,外周器官疾病等。